Science Resources RSS Feeds
|
 |
 |
 |
Huntington Disease Current Events | Huntington Disease News
|
|
|
Sort By:
Page Views | Date |
New hope for treatment of neurodegenerative disorder
Researchers from the University of Southern California have taken an important first step toward protecting against Huntington disease using gene therapy. view more (2009-04-21)
Huntington disease begins to take hold early on
A global analysis of brain proteins over a 10-week period in a mouse model of Huntington Disease has revealed some new insights into this complex neurodegenerative disorder. view more (2009-04-17)
New hope for Huntington's sufferers
A major breakthrough in the understanding and potential treatment of Huntington's disease has been made by scientists at the University of Leeds. view more (2007-08-23)
Cure found for Huntington disease in mice offers hope for treatment in humans
Researchers at the University of British Columbia's Centre for Molecular Medicine and Therapeutics (CMMT) have provided ground-breaking evidence for a cure for Huntington disease in a mouse offering hope that this disease can be relieved in humans. view more (2006-06-16)
Century of data shows intensification of water cycle but no increase in storms or floods
A review of the findings from more than 100 peer-reviewed studies shows that although many aspects of the global water cycle have intensified, including precipitation and evaporation, this trend has not consistently resulted in an increase in the frequency or intensity of tropical storms or floods over the past century. view more (2006-03-16)
Prozac improves learning and memory in fatal brain disease
Howard Florey Institute scientists in Melbourne have found that fluoxetine (commonly marketed as Prozac®) not only improves depression in Huntington's disease, but also improves learning and memory. view more (2005-10-07)
A new molecular zip code, and a new drug target for Huntington's disease
McMaster University researchers have first insight into how Huntington's disease (HD) is triggered. The research will be published online in the British Journal, Human Molecular Genetics, on Monday, August 20. view more (2007-08-21)
Study Finds Drug May Cut Down Involuntary Movements in Huntington's Disease Patients By 25 Percent
The medication tetrabenazine cut down involuntary movement in patients with Huntington's disease on average by about 25 percent, with many patients experiencing a greater improvement. view more (2006-02-16)
Abnormal glutamine repeats interfere with key transcription factor, leading to neurodegeneration
Although repeating sequences of three nucleotides encoding some of the bodies' 20 amino acids are a normal part of protein composition, abnormal expansion of trinucleotide repeats is the known cause of multiple inherited neurodegenerative disorders, including Huntington disease. view more (2007-11-14)
Research suggests cause of neurodegeneration in Huntington's disease
The severe neurodegeneration associated with Huntington's disease may result from molecular mutations that block the transport of nutrients within cells. view more (2006-05-31)
Drug aimed at Huntington's eases chorea, the disease's hallmark feature
A drug widely available in Europe and Canada - but not the United States - dramatically eases one of the most disabling symptoms of Huntington's disease, involuntary writhing movements known as chorea. view more (2006-02-14)
Stowers Institute's Workman Lab discovers novel histone demethylase protein complex
The Stowers Institute's Workman Lab has discovered a novel histone demethylase protein complex characterized in work published today in Molecular Cell. view more (2008-12-08)
MIT research holds promise for Huntington's treatment
Researchers at MIT and Harvard Medical School have identified a compound that interferes with the pathogenic effects of Huntington's disease, a discovery that could lead to development of a new treatment for the disease. view more (2006-03-09)
Old drug shows new promise for Huntington's Disease
Clioquinol, an antibiotic that was banned for internal use in the United States in 1971 but is still used in topical applications, appears to block the genetic action of Huntington's disease in mice and in cell culture, according to a study reported by San Francisco VA Medical Center (SFVAMC) researchers. view more (2005-09-12)
Study identifies potential drug target for Huntington's disease
An enzyme known to be critical for the repair of damaged cells and the maintenance of cellular energy may be a useful target for new strategies to treat Huntington's disease (HD) and other disorders characterized by low cellular energy levels. view more (2006-07-31)
Tufts University biologists link Huntington's disease to health benefits in young
For years researchers in neurology have believed that people with Huntington's disease have more children than the general population because of behavioral changes associated with the disease that lead to sexual promiscuity. view more (2007-09-26)
Proteasome activator enhances survival of Huntington's disease neuronal model cells
To function, each living cell needs both to build new and to degrade old or damaged proteins. To accomplish that, a number of intracellular systems work in concert to keep the cell healthy and from clogging up with damaged proteins. view more (2007-02-28)
Researchers estimate risk of transmission of Huntington's disease to offspring among male carriers
Researchers from Boston University School of Medicine (BUSM) have quantified the probability of a male who carries a "high normal" variant of the Huntington's Disease (HD) gene having a child who develops the disease. view more (2009-06-10)
Mechanism identified for promising neurological drug
Researchers at the San Francisco VA Medical Center have identified the mechanism by which minocycline, a medication currently being studied for the treatment of neurodegenerative diseases including Parkinson's disease and Huntington's disease, protects brain and nerve cells from damage. view more (2006-06-22)
Mayo Clinic research collaboration discovers why some DNA repair fails
Mayo Clinic researchers have discovered the inner workings of a defective DNA repair process and are first to explain why certain mutations are not corrected in cells. view more (2005-10-04)
|
|
|
|
Sort By:
Page Views | Date |
|
|
